Kyverna Therapeutics, Inc.
KYTX
$9.40
$0.040.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 63.17% | -19.15% | -12.76% | -15.15% | -11.07% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 92.76% | 42.91% | -47.02% | 8.22% | 22.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 61.76% | -18.38% | -13.46% | -14.78% | -10.69% |
|
|
|||||
| Total Current Assets | 61.76% | -18.38% | -13.46% | -14.78% | -10.69% |
| Net Property, Plant & Equipment | -14.28% | -16.56% | -13.93% | -17.39% | -6.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.70% | 28.34% | 9.59% | 24.00% | 38.85% |
| Total Assets | 57.00% | -17.37% | -13.10% | -14.44% | -10.19% |
|
|
|||||
| Total Accounts Payable | 75.93% | -69.59% | 17.06% | 83.22% | -53.44% |
| Total Accrued Expenses | 0.15% | 3.32% | 23.83% | -15.71% | 47.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.71% | 3.05% | -0.25% | -9.01% | 0.23% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.72% | -14.87% | 19.52% | -1.37% | 8.94% |
|
|
|||||
| Total Current Liabilities | 7.72% | -14.87% | 19.52% | -1.37% | 8.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -76.10% | -42.83% | -30.15% | -22.06% | -17.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 74.81% | -16.43% | 14.97% | -3.71% | 4.31% |
|
|
|||||
| Common Stock & APIC | 21.91% | 0.81% | 0.46% | 0.41% | 0.27% |
| Retained Earnings | -9.77% | -10.50% | -13.66% | -16.94% | -16.59% |
| Treasury Stock & Other | 234.48% | 245.00% | -1,900.00% | -100.95% | -31.37% |
| Total Common Equity | 52.87% | -17.59% | -17.69% | -15.97% | -11.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.87% | -17.59% | -17.69% | -15.97% | -11.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.87% | -17.59% | -17.69% | -15.97% | -11.93% |
|
|
|||||